Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Return on Invested Capital (2022 - 2025)

Xeris Biopharma Holdings filings provide 4 years of Return on Invested Capital readings, the most recent being 0.0% for Q2 2025.

  • On a quarterly basis, Return on Invested Capital changed 0.0% to 0.0% in Q2 2025 year-over-year; TTM through Jun 2025 was 0.0%, a 0.0% change, with the full-year FY2024 number at 0.0%, changed 0.0% from a year prior.
  • Return on Invested Capital hit 0.0% in Q2 2025 for Xeris Biopharma Holdings, up from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q2 2025 to a low of 0.01% in Q1 2022.
  • Median Return on Invested Capital over the past 4 years was 0.0% (2023), compared with a mean of 0.0%.
  • The widest YoY moves for Return on Invested Capital: up 0bps in 2023, down 0bps in 2023.
  • Xeris Biopharma Holdings' Return on Invested Capital stood at 0.0% in 2022, then skyrocketed by 40bps to 0.0% in 2023, then increased by 27bps to 0.0% in 2024, then surged by 73bps to 0.0% in 2025.
  • The last three reported values for Return on Invested Capital were 0.0% (Q2 2025), 0.0% (Q1 2025), and 0.0% (Q4 2024) per Business Quant data.